Skip to content

13F-HR filed by Avoro Capital Advisors LLC

Avoro Capital Advisors LLC filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-14, with 50 holding rows worth $1,542,805,000.

Accession
0001144204-18-008486
Filed
2018-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2017

A holdings report, 52 entries on the cover page, a total value of $1,542,805,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,542,805,000 with VALUE read as thousands by filing date, 13F file number 028-16573. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
IMMUNOMEDICS INC452907108COM16,064,461$259,602,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM1,189,524$106,070,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM7,263,122$104,516,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM4,398,101$80,265,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM1,102,884$74,996,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM1,841,896$72,479,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock5,468,029$69,991,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR1,681,024$67,342,000thousands by filing date
AVEXIS INC05366U100COM596,217$65,983,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS4,436,183$64,768,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR804,875$50,820,000thousands by filing date
ZOGENIX INC.98978L204Common Stock1,263,313$50,596,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM1,068,534$48,351,000thousands by filing date
DERMIRA INC24983L104COM1,520,000$42,271,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM5,253,450$42,028,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock848,572$38,737,000thousands by filing date
MEDICINES CO584688105COM1,296,560$35,448,000thousands by filing date
Bristol-Myers Squibb Company110122108COM456,223$27,957,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock3,294,463$27,015,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR750,300$26,035,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM1,408,946$21,416,000thousands by filing date
TELIGENT INC NEW87960W104COM5,049,431$18,329,000thousands by filing date
MYOKARDIA INC62857M105COM398,207$16,765,000thousands by filing date
CATALYST PHARMACEUTICALS INC14888U101COM3,892,343$15,219,000thousands by filing date
INTEC PHARMA LTD JERUSALEMM53644106SHS2,195,705$11,308,000thousands by filing date
AVEO PHARMACEUTICALS INC053588109COM4,006,893$11,179,000thousands by filing date
CASCADIAN THERAPEUTICS INC14740B606COM NEW2,485,272$9,196,000thousands by filing date
ALIMERA SCIENCES INC016259103COM6,241,581$8,301,000thousands by filing date
IMMUNOMEDICS INC452907108COM875,000$8,225,000thousands by filing datecall
AGENUS INC00847G705COM NEW2,439,554$7,953,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM396,635$7,316,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM2,469,488$7,285,000thousands by filing date
NEWLINK GENETICS CORP651511107COM795,412$6,451,000thousands by filing date
Viewra, Inc92672L107COM730,161$5,824,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM400,000$5,456,000thousands by filing date
VIVEVE MED INC92852W204COM NEW1,033,276$5,135,000thousands by filing date
VERACYTE INC COM92337F107Stock752,455$4,914,000thousands by filing date
INCYTE CORP COM45337C102Stock50,000$4,736,000thousands by filing date
FENNEC PHARMACEUTICALS INC31447P100COMMON STOCK206,000$2,726,000thousands by filing date
PERNIX THERAPEUTICS HLDGS IN71426VAK4DBCV 4.250 4/06,000,000$2,530,000thousands by filing dateprincipal
CELLECTIS ADS15117K103COM78,289$2,282,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM1,500,000$1,763,000thousands by filing datecall
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock340,821$1,673,000thousands by filing date
ONCOBIOLOGICS INC68235M105COM683,531$889,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM675,000$264,000thousands by filing datecall
ARRAY BIOPHARMA INC COM04269X105Stock75,000$216,000thousands by filing datecall
BIOMARIN PHARMACEUTICAL INC09061G101COM300,000$135,000thousands by filing datecall
MACROGENICS INC556099109COM14,500$37,000thousands by filing datecall
ONCOBIOLOG-CW17A68235M113EQUITY WRT233,333$7,000thousands by filing date
ONCOBIOLOGICS INC68235M121*W EXP 05/18/201233,333$5,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001144204-18-008486this filing2018-02-14acceptance time not in the bulk data set